The effect of sirolimus- or cyclosporine-based immunosuppression effects on T-cell subsets in vivo

Kidney International

Volumn 72, Issue 1, 2007, Pages 114-120

  Libetta, C ^a,b   Sepe, V ^a   Zucchi, M ^a   Portalupi, V ^a   Meloni, F ^a   Rampino, T ^a   Canton, A Dal ^a  

^a UNIVERSITY OF PAVIA   (Italy)

^b FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

Author keywords

Cyclosporine A; Cytokines; Immunosuppression; Kidney transplantation; Sirolimus; T helper

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; CREATININE; CYCLOSPORIN A; GAMMA INTERFERON; INTERLEUKIN 12; INTERLEUKIN 18; INTERLEUKIN 4; INTERLEUKIN 5; LIPOPOLYSACCHARIDE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHYTOHEMAGGLUTININ; RAPAMYCIN;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIGEN PRESENTING CELL; ARTHRALGIA; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CADAVER KIDNEY; CELL SEPARATION; CELL TRANSFORMATION; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CYTOKINE PRODUCTION; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; HYPERCHOLESTEROLEMIA; HYPERGLYCEMIA; HYPERTENSION; HYPERTRIGLYCERIDEMIA; IMMUNOSUPPRESSIVE TREATMENT; IMPAIRED GLUCOSE TOLERANCE; IN VIVO STUDY; IRRADIATION; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LOADING DRUG DOSE; LYMPHOCYTE DEPLETION; MALE; PRIORITY JOURNAL; RANDOMIZATION; SIDE EFFECT; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL; THROMBOCYTE COUNT; THROMBOCYTOPENIA;

ADULT; ANTI-INFLAMMATORY AGENTS; CELLS, CULTURED; CYCLOSPORINE; FEMALE; GENE EXPRESSION REGULATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTERFERON TYPE II; INTERLEUKIN-12; INTERLEUKIN-18; INTERLEUKIN-4; INTERLEUKIN-5; KIDNEY TRANSPLANTATION; MALE; METHYLPREDNISOLONE; MIDDLE AGED; MONOCYTES; MYCOPHENOLIC ACID; SIROLIMUS; TH1 CELLS; TH2 CELLS;

EID: 34347352114     PISSN: 00852538     EISSN: 15231755     Source Type: Journal    
DOI: 10.1038/sj.ki.5002255     Document Type: Article

References (40)

1. Nankivell BJ, Borrows RJ, Fung CL et al. The natural history of chronic allograft nephropathy. N Engl J Med 2003; 349: 2326-2333.
2. Burdmann EA, Andoh TF, Yu L, Bennett WM. Cyclosporine nephrotoxicity. Semin Nephrol 2003; 23: 465-476.
3. Halloran PF. Immunosuppressive drug for kidney transplantation. N Engl J Med 2004; 351: 2715-2729.
4. Kahan BD. Sirolimus: a ten-year perspective. Transplant Proc 2004; 36: 71-75.
5. Kirken RA, Wang YL. Molecular actions of sirolimus: sirolimus and mTor. Transplant Proc 2003; 35(S3A): 227-230.
6. Kuo CJ, Chung J, Fiorentino DF. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. Nature 1992; 358: 70-73.
7. Nickerson P, Steurer W, Steiger J et al. Cytokines and the Th1/Th2 paradigm in transplantation. Curr Opin Immunol 1994; 6: 757-762.
8. Divate SA. Acute renal allograft rejection: progress in understanding cellular and molecular mechanisms. J Postgrad Med 2000; 46: 293-296.
9. Nagai T, Devergne O, Mueller TF et al. Timing of IFN-beta exposure during human dendritic cell maturation and naive Th cell stimulation has contrasting effects on Th1 subset generation: a role for IFN-beta-mediated regulation of IL-12 family cytokines and IL-18 in naive Th cell differentiation. J Immunol 2003; 171: 5233-5243.
10. O'Connel PJ, Pacheco-Silva A, Nickerson PW. Unmodified pancreatic islet allorgraft rejaction results in the preferential expression of certain T cell activation transcripts. J Immunol 1993; 150: 1093-1097.
11. Nast CC, Zuo XJ, Prehn J et al. Gamma-interferon gene expression in human renal allograft fine-needle aspirates. Transplantation 1994; 57: 498-502.
12. Kirk AD, Bollinger RR, Finn OJ. Rapid, comprehensive analysis of human cytokine mRNA and its application to the study of acute renal allograft rejection. Human Immunol 1995; 43: 113-119.
13. Heeger PS, Greenspan NS, Kuhlenschmidt S et al. Pretransplant frequency of donor-specific IFN-producing lymphocytes is a manifestation of immunologic memory and correlates with the risk of posttransplant rejection episodes. J Immunol 1999; 163: 2267-2275.
14. Najafian N, Salama AD, Fedoseyeva EV et al. Enzyme-linked immunosorbent spot assay analysis of peripheral blood lymphocyte reactivity to donor HLA-DR peptides: potential novel assay for prediction of outcomes for renal transplant recipients. J Am Soc Nephrol 2002; 13: 252-259.
15. Zelenika D, Adams E, Humm S et al. The role of CD4+ T-cell subsets in determining transplantation rejection or tollerance. Immunol Rev 2001; 182: 164-179.
16. Weigle WO, Romball CG. CD4+ T-cell subsets and cytokines involved in peripheral tolerance. Immunol Today 1997; 18: 533-538.
17. Saunders RN, Metcalfe MS, Nicholson ML. Rapamycin in transplantation: a review of evidence. Kidney Int 2001; 59: 3-16.
18. VanBuskirk AM, Wakely ME, Orosz CG. Transfusion of polarised Th2-like cell populations into SCID mouse cardiac allograft recipients results in acute allograft rejection. Transplantation 1996; 62: 229-234.
19. Zheng XX, Strom TB, Steele AW. Quantitative comparison of rapamycin and cyclosporine effects on cytokine gene expression studied by reverse transcriptase-competitive polymerase chain reaction. Transplantation 1994; 58: 87-92.
20. Chiang PH, Wang L, Liang Y et al. Inhibition of IL-12 signaling Stat4/INF pathway by rapamycin is associated with impaired dendritic cell function. Transplant Proc 2002; 34: 1394-1395.
21. Valentine JE, Sewell WA. Induction of IL-5 expression by IL-2 is resistant to the immunosuppressive agents cyclosporin A and rapamycin. Int Immunol 1997; 9: 975-982.
22. Coughlin CM, Salhany KE, Wysocka M et al. Interleukin-12 and interleukin-18 synergically induce murine tumor regression which involves inhibition of angiogenesis. J Clin Invest 1998; 101: 1441-1452.
23. Takeda K, Tsutsui H, Yoshimoto T et al. Defective NK cell activity and Th1 response in IL-18-deficient mice. Immunity 1998; 8: 383-390.
24. Robinson D, Shibuya K, Mui A et al. IGIF does not drive Th1 development but synergizes with IL-12 for interferon-g production and activates IRAK and NFkB. Immunity 1997; 7: 571-581.
25. Seder RA, Gazzinelli R, Sher A, Paul WE. Interleukin 12 acts directly on CD4+ T cell to enhance priming for interferon-g production and diminishes interleukin 4 inhibition of such priming. Proc Natl Acad Sci USA 1993; 90: 10188-10192.
26. Sordi V, Bianchi G, Buracchi C et al. Differential effects of immunosuppressive drugs on chemokine receptor CCR7 in human monocyte-derived dendritic cells: selective upregulation by rapamycin. Transplantation 2006; 82: 826-834.
27. Chiang P-H, Wang L, Bonham A et al. Mechanistic insights into impaired dendritic cell function by rapamycin: inhibition of Jak2/Stat4 signaling pathway. J Immunol 2004; 172: 1355-1363.
28. Monti P, Mercalli A, Leone BE et al. Rapamycin impairs antigen uptake of human dendritic cells. Transplantation 2003; 75: 137-145.
29. Tao R, Wang L, Chen CH et al. Mechanistic insights into achievement of cardiac allograft long-term survival by treatment with immature dendritic cells and sub-dose sirolimus. J Heart Lung Transplant 2006; 25: 310-319.
30. Waldmann H, Cobbold S. The use of monoclonal antibodies to achieve immunological tolerance. Immunol Today 1993; 14: 247-251.
31. Coenen JJ, Koenen HJ, van Rijssen E et al. Rapamycin, and not cyclosporin A, preserves the highly suppressive CD27+ subset of human CD4-CD25+ regulatory T cells. Blood 2006; 107: 1018-1023.
32. Strauss L, Whiteside TL, Knights A et al. Selective survival of naturally occurring human CD4+CD25+Foxp3+ regulatory T cells cultured with rapamycin. J Immunol 2007; 178: 320-329.
33. Battaglia M, Stabilini A, Migliavacca B et al. Rapamycin promotes expansion of functional CD4+CD25+Foxp3+ regulatory T cells of both healthy subjects and type 1 diabetic patients. J Immunol 2006; 177: 8338-8347.
34. Romagnani S, Parronchi P, D'Elios MM et al. An update on human Th1 and Th2 cells. Int Arch Allergy Immunol 1997; 113: 153-156.
35. Marone Bianco A, Solari N, Miserere S et al. The frequency of interleukin-10- and interleukin-5-secreting CD4 T cells correlates to tolerance of transplanted lung. Transplant Proc 2005; 37: 2255-2256.
36. Tsirpanlis G, Bagos P, Ioannou D et al. The variability and accurate assessment of microinflammation in hemodialysis patients. Nephrol Dial Transplant 2004; 19: 150-157.
37. Cattaneo D, Perico N, Gaspari F. Assessment of sirolimus concentration in whole blood by high-performance liquid chromatography with ultraviolet detection. J Chromatogr 2002; 774: 187-194.
38. Libetta C, Zucchi M, Gori E et al. Vitamin E-loaded dialyzer resets PBMC-operated cytokine network in dialysis patients. Kidney Int 2004; 65: 1473-1481.
39. Libetta C, Rampino T, Palumbo G et al. Circulating serum lectins of patients with IgA nephropathy stimulate IL-6 release from mesangial cells. J Am Soc Nephrol 1997; 8: 208-213.
40. Meloni F, Paschetto E, Cascina A et al. Evaluation with enzyme-linked immunosorbent assay spot detection of the frequency of interferon-gamma-producing T cells in bronchoalveolar lavage is useful in identifying lung transplant patients at higher risk of acute rejection. Transplant Proc 2001; 33: 3286-3288.